A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy Volunteers
Clinical trial NCT03792308 · COMPLETED
Trial details
- NCT number
- NCT03792308
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2019-12-23
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.